K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth

被引:0
|
作者
Efterpi Dalpa
Victor Gourvas
Nikolaos Soulitzis
Demetrios A. Spandidos
机构
[1] University of Crete,Laboratory of Clinical Virology, Medical School
来源
Medical Oncology | 2017年 / 34卷
关键词
Nephroblastoma; RFLP; qPCR; Biomarkers; Oncogenes;
D O I
暂无
中图分类号
学科分类号
摘要
Nephroblastoma (Wilms tumor) is a kidney neoplasia, predominately occurring at very young age, resulting from the malignant transformation of renal stem cells. The Ras proto-oncogenes and B-Raf are members of an intracellular cascade pathway, which regulates cell growth and differentiation, and ultimately cancer development. Our objective was to determine the mutation rate and to measure the mRNA levels of the three Ras genes and of B-Raf in formalin-fixed paraffin-embedded tissue samples from 32 patients with nephroblastoma and 10 controls. No mutations were detected in the four studied genes among our Wilms tumors cases, while Ras and B-Raf expression was higher in malignant samples versus controls. Statistical analysis revealed a positive correlation of K-Ras (p < 0.001) and B-Raf (p = 0.006) with tumor size, a negative correlation of K-Ras (p = 0.041) and H-Ras (p = 0.033) with the percentage of tissue necrosis, and an association of N-Ras (p = 0.047) and B-Raf (p = 0.044) with tissue histology. From the above, we deduce that although Ras and B-Raf mutations are rare events in Wilms tumors, their expression pattern suggests that they play an important role in the development and progression of this malignancy.
引用
收藏
相关论文
共 50 条
  • [1] K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth
    Dalpa, Efterpi
    Gourvas, Victor
    Soulitzis, Nikolaos
    Spandidos, Demetrios A.
    [J]. MEDICAL ONCOLOGY, 2017, 34 (01)
  • [2] Mutation and expression analysis of K-Ras, H-Ras, N-Ras and B-Raf oncogenes in Wilms tumors
    Dalpa, Efterpi
    Gourvas, Victor
    Soulitzis, Nikolaos
    Spandidos, Demetrios A.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S93 - S93
  • [3] ANALYSIS OF H-RAS, K-RAS AND N-RAS GENES FOR EXPRESSION, MUTATION AND AMPLIFICATION IN LARYNGEAL TUMORS
    KIARIS, H
    SPANDIDOS, DA
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (01) : 75 - 80
  • [4] N-RAS, H-RAS, AND K-RAS - A DIFFERENCE IN TRANSFORMING POTENTIAL
    MAHER, J
    BAKER, DA
    DIBB, NJ
    ROBERTS, IAG
    [J]. BLOOD, 1994, 84 (10) : A295 - A295
  • [5] H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers
    Przybojewska, B
    Jagiello, A
    Jalmuzna, P
    [J]. CANCER GENETICS AND CYTOGENETICS, 2000, 121 (01) : 73 - 77
  • [6] Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors
    Vageli, D
    Kiaris, H
    Delakas, D
    Anezinis, P
    Cranidis, A
    Spandidos, DA
    [J]. CANCER LETTERS, 1996, 107 (02) : 241 - 247
  • [7] Analysis of K-ras, N-ras, H-ras, and p53 in lung neuroendocrine neoplasms
    Couce, ME
    Bautista, D
    Costa, J
    Carter, D
    [J]. DIAGNOSTIC MOLECULAR PATHOLOGY, 1999, 8 (02) : 71 - 79
  • [8] Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients
    Malgorzata Banys-Paluchowski
    Karin Milde-Langosch
    Tanja Fehm
    Isabell Witzel
    Leticia Oliveira-Ferrer
    Barbara Schmalfeldt
    Volkmar Müller
    [J]. Breast Cancer Research and Treatment, 2020, 179 : 403 - 414
  • [9] Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients
    Banys-Paluchowski, Malgorzata
    Milde-Langosch, Karin
    Fehm, Tanja
    Witzel, Isabell
    Oliveira-Ferrer, Leticia
    Schmalfeldt, Barbara
    Mueller, Volkmar
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (02) : 403 - 414
  • [10] Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma
    van Dijk, MCRF
    Bernsen, MR
    Ruiter, DJ
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) : 1145 - 1151